Skip to main content

Table 5 Summary estimates of the odds ratio (OR) for the associations of High Ki-67 expression and clinical-pathological features of lymphoma

From: Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis

  Heterogeneity
Clinicopathological features Nuber of studies Nuber of patients Pooled OR(95% CI) P value I2(%) P value
Performance status (0–1 vs.2-5) 7 643 1.082(0.654-1.793) 0.758 31.7 0.186
Elevated LDH (normal vs. elevated) 10 884 0.914(0.673-1.241) 0.564 36.6 0.115
IPI score (0–2 vs.3-5) 7 611 0.963(0.667-1.39) 0.84 0 0.53
Tumor stage (I-II vs. III-IV) 9 845 1.089(0.79-1.501) 0.604 37.4 0.119
B symptom (no vs. yes) 10 944 0.851(0.557-1.3) 0.455 45 0.059
Extranodal site (no vs. yes) 9 758 1.017(0.674-1.534) 0.937 20.7 0.259